About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.

Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.

Patient Information:

• Name: Faisal Salem
• Diagnosis: Type-2 Diabetes (with Diabetic Nephropathy, Multiple Cerebral Infarction, Right Internal Carotid Artery Occlusion)
• Date of Birth (D.O.B): August 5, 1971
• Gender: Male
• Country: Saudi Arabia

Treatment: Nerve Growth Factor Therapy; medications to enhance peripheral circulation; neuronal nutritional support at Beijing Puhua International Hospital

Medical History:
Faisal was diagnosed with Type II Diabetes Mellitus in 2002, presenting with polydipsia, diuresis, and weight loss. Initially prescribed oral medications, his blood glucose control remained poor due to non-adherence to diabetic diet and exercise therapy. Insulin therapy was initiated, consisting of Aspart 15 Units TID and Glargine 30 Units QD; however, glycemic control was still suboptimal, leading to his admission at Beijing Puhua International Hospital for further management.

Medical Condition before Nerve Growth Factor Therapy:

• Weakness
• Frequent and severe hypoglycemia (4 episodes) despite insulin therapy
• Intolerance to heat with diaphoresis
• Poor dietary control
• Normal urine output but alternating diarrhea and constipation
• Laboratory findings: blood glucose 16.55 mmol/L (high), ALB 33.64 g/L (low), HbA1c 10.30% (high)

Nerve Growth Factor Therapy for Type-2 Diabetes:
Following admission, Faisal received the following treatment regimen:

• Adjustment of hypoglycemic therapy
• Nerve growth factor implantation via intravenous injections
• Traditional Chinese Medicine support

Medical Condition after Nerve Growth Factor Therapy:
Post-Nerve Growth Factor Therapy, Faisal's insulin dosage was gradually reduced due to improved glycemic control. His renal function also demonstrated improvement, with urine protein levels decreasing from 2+ to 1+. Additionally, his HbA1c level decreased from 10.3% to 8%, and blood glucose levels became more stable. Faisal reported better adherence to healthy diets and moderate physical exercise post-treatment. Further progress would require ongoing management and follow-up assessment.